Letter: direct-acting anti-viral (DAA) therapy needs strong safety and efficacy check-authors' reply

Aliment Pharmacol Ther. 2018 Jul;48(2):235-236. doi: 10.1111/apt.14820.

Authors

A W Singer¹, K R Reddy², L E Telep¹, A O Osinusi¹, D M Brainard¹, M Buti³, A P Chokkalingam^{1

4}

Affiliations

¹ Gilead Sciences Inc., Foster City, CA, USA.
² Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
³ Hospital General Universitari Vall d'Hebron, Barcelona, Spain.
⁴ School of Public Health, University of California, Berkeley, CA, USA.

PMID: 29939414
DOI: 10.1111/apt.14820

No abstract available

Publication types

Letter
Comment

MeSH terms

Adult
Antiviral Agents*
Hepacivirus
Hepatitis C, Chronic*
Humans
Liver Neoplasms*
Retrospective Studies

Substances

Antiviral Agents